| Cancer immunotherapy: the beginning of the end of cancer? S Farkona, EP Diamandis, IM Blasutig BMC medicine 14, 1-18, 2016 | 1368 | 2016 |
| Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes N Jones, IM Blasutig, V Eremina, JM Ruston, F Bladt, H Li, H Huang, ... Nature 440 (7085), 818-823, 2006 | 560 | 2006 |
| The long journey of cancer biomarkers from the bench to the clinic MP Pavlou, EP Diamandis, IM Blasutig Clinical chemistry 59 (1), 147-157, 2013 | 190 | 2013 |
| Validation of biomarkers that complement CA19. 9 in detecting early pancreatic cancer A Chan, I Prassas, A Dimitromanolakis, RE Brand, S Serra, EP Diamandis, ... Clinical Cancer Research 20 (22), 5787-5795, 2014 | 143 | 2014 |
| Phosphorylated YDXV motifs and Nck SH2/SH3 adaptors act cooperatively to induce actin reorganization IM Blasutig, LA New, A Thanabalasuriar, TK Dayarathna, M Goudreault, ... Molecular and cellular biology 28 (6), 2035-2046, 2008 | 125 | 2008 |
| Nck proteins maintain the adult glomerular filtration barrier N Jones, LA New, MA Fortino, V Eremina, J Ruston, IM Blasutig, L Aoudjit, ... Journal of the American Society of Nephrology 20 (7), 1533-1543, 2009 | 123 | 2009 |
| Non-canonical interaction of phosphoinositides with pleckstrin homology domains of Tiam1 and ArhGAP9 DFJ Ceccarelli, IM Blasutig, M Goudreault, Z Li, J Ruston, T Pawson, ... Journal of Biological Chemistry 282 (18), 13864-13874, 2007 | 111 | 2007 |
| Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues H Kosanam, I Prassas, CC Chrystoja, I Soleas, A Chan, ... Molecular & Cellular Proteomics 12 (10), 2820-2832, 2013 | 110 | 2013 |
| Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19. 9 S Makawita, A Dimitromanolakis, A Soosaipillai, I Soleas, A Chan, ... BMC cancer 13, 1-11, 2013 | 78 | 2013 |
| Strategies for discovering novel pancreatic cancer biomarkers A Chan, EP Diamandis, IM Blasutig Journal of proteomics 81, 126-134, 2013 | 72 | 2013 |
| Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobas® 6000 analyzer—A CALIPER pilot study V Kulasingam, BP Jung, IM Blasutig, S Baradaran, MK Chan, M Aytekin, ... Clinical biochemistry 43 (13-14), 1045-1050, 2010 | 66 | 2010 |
| Candidate recommendations for protein electrophoresis reporting from the Canadian society of clinical chemists monoclonal gammopathy working group RA Booth, CR McCudden, CM Balion, IM Blasutig, I Bouhtiauy, ... Clinical Biochemistry 51, 10-20, 2018 | 59 | 2018 |
| False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125 I Prassas, D Brinc, S Farkona, F Leung, A Dimitromanolakis, CC Chrystoja, ... Clinical Chemistry 60 (2), 381-388, 2014 | 52 | 2014 |
| Definitive characterization of CA 19-9 in resectable pancreatic cancer using a reference set of serum and plasma specimens BB Haab, Y Huang, S Balasenthil, K Partyka, H Tang, M Anderson, ... PloS one 10 (10), e0139049, 2015 | 42 | 2015 |
| Analytical evaluation of the VITROS® 5600 Integrated System in a pediatric setting and determination of pediatric reference intervals IM Blasutig, B Jung, V Kulasingam, S Baradaran, Y Chen, MK Chan, ... Clinical biochemistry 43 (13-14), 1039-1044, 2010 | 40 | 2010 |
| Determination of the Plk4/Sak consensus phosphorylation motif using peptide spots arrays GC Leung, CSW Ho, IM Blasutig, JM Murphy, F Sicheri FEBS letters 581 (1), 77-83, 2007 | 39 | 2007 |
| Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer D Korbakis, A Dimitromanolakis, I Prassas, GJ Davis, E Barber, ... British journal of cancer 113 (3), 484-491, 2015 | 35 | 2015 |
| Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity AA Venner, D Ibañez, DD Gladman, MB Urowitz, A MacKinnon, ... Clinical biochemistry 46 (4-5), 317-320, 2013 | 35 | 2013 |
| Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer AWS Fung, MJ Knauer, IM Blasutig, DA Colantonio, V Kulasingam F1000Research 6, 2017 | 34 | 2017 |
| Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPAPlus NMA White-Al Habeeb, T Earle, M Spencer, IM Blasutig Clinical biochemistry 51, 90-96, 2018 | 29 | 2018 |
